Stig Løkke Pedersen of Lundbeck resigns
This article was originally published in Scrip
Stig Løkke Pederson, executive vice-president of commercial operations for Lundbeck, has resigned to pursue new opportunities. He joined the company in 1992 and has been part of the corporate senior management team since 1998, and executive vice-president since 2003. He will remain available to Lundbeck after his resignation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.